Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $12.04 million. The enterprise value is $2.99 million.

Market Cap	12.04M
Enterprise Value	2.99M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Imunon has 14.50 million shares outstanding. The number of shares has increased by 15.30% in one year.

Current Share Class	14.50M
Shares Outstanding	14.50M
Shares Change (YoY)	+15.30%
Shares Change (QoQ)	+53.66%
Owned by Insiders (%)	4.89%
Owned by Institutions (%)	7.00%
Float	13.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.47
P/TBV Ratio	1.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.15.

Current Ratio	2.30
Quick Ratio	1.89
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -148.12% and return on invested capital (ROIC) is -89.50%.

Return on Equity (ROE)	-148.12%
Return on Assets (ROA)	-67.08%
Return on Capital (ROIC)	-89.50%
Revenue Per Employee	n/a
Profits Per Employee	-$589,429
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.46% in the last 52 weeks. The beta is 2.09, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	2.09
52-Week Price Change	-9.46%
50-Day Moving Average	0.87
200-Day Moving Average	1.15
Relative Strength Index (RSI)	47.10
Average Volume (20 Days)	395,121

Short Selling Information

The latest short interest is 738,626, so 5.09% of the outstanding shares have been sold short.

Short Interest	738,626
Short Previous Month	702,037
Short % of Shares Out	5.09%
Short % of Float	5.67%
Short Ratio (days to cover)	3.31

Income Statement

Revenue	n/a
Gross Profit	-1.67M
Operating Income	-20.95M
Pretax Income	-20.13M
Net Income	-19.45M
EBITDA	-20.68M
EBIT	-20.95M
Earnings Per Share (EPS)	-$1.90

Full Income Statement

Balance Sheet

The company has $10.31 million in cash and $1.27 million in debt, giving a net cash position of $9.05 million or $0.62 per share.

Cash & Cash Equivalents	10.31M
Total Debt	1.27M
Net Cash	9.05M
Net Cash Per Share	$0.62
Equity (Book Value)	8.19M
Book Value Per Share	0.56
Working Capital	7.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.21 million and capital expenditures -$14,634, giving a free cash flow of -$18.22 million.

Operating Cash Flow	-18.21M
Capital Expenditures	-14,634
Free Cash Flow	-18.22M
FCF Per Share	-$1.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.30%
Shareholder Yield	-15.30%
Earnings Yield	-161.61%
FCF Yield	-151.39%

Analyst Forecast

The average price target for Imunon is $20.50, which is 2,369.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.50
Price Target Difference	2,369.88%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1